GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intravenous Infusions Ltd (XGHA:IIL) » Definitions » Capital Expenditure

Intravenous Infusions (XGHA:IIL) Capital Expenditure : GHS0.00 Mil (TTM As of . 20)


View and export this data going back to 2015. Start your Free Trial

What is Intravenous Infusions Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Intravenous Infusions's cash flow for capital expenditures for the six months ended in . 20 was GHS0.00 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in . 20 was GHS0.00 Mil.

Intravenous Infusions Capital Expenditure Historical Data

The historical data trend for Intravenous Infusions's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intravenous Infusions Capital Expenditure Chart

Intravenous Infusions Annual Data
Trend
Capital Expenditure

Intravenous Infusions Semi-Annual Data
Capital Expenditure

Intravenous Infusions Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Capital Expenditure for the trailing twelve months (TTM) ended in . 20 was GHS0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Intravenous Infusions (XGHA:IIL) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intravenous Infusions Ltd (XGHA:IIL) » Definitions » Capital Expenditure
Comparable Companies
BOM:531015 BOM:524516 BOM:539680 BOM:531521 PTLF BOM:524590 BOM:524606 BOM:536565 PCYN BOM:532021 BOM:540359 TSXV:CIP.H BOM:531686 BOM:524314 BOM:511523 FRA:3SQ1 BOM:532167 BOM:524632 YBAO BKIT
Traded in Other Exchanges
N/A
Address
Plot 4/7 Blk L, P.O Box KF 63, Effiduase-Koforidua, GHA
Website
https://www.iil.com.gh
Intravenous Infusions Ltd engages in the production of intravenous infusion and small-volume injectables for therapeutic purposes. The product categories are IV fluids, giving sets, and small-volume injectables. The company earns a majority of its revenue from IV fluids. Some of the IV fluids are sodium chloride solutions, dextrose solutions, dextrose saline solutions, and dextran solutions. Small-volume injectables include pethidine injection, magnesium sulphate injection, and quinine injection. Giving sets include plain giving sets, and blood giving sets.